RVX-208: A SMALL MOLECULE THAT INCREASES APOA-I, HDL-C, AND CHOLESTEROL EFFLUX

被引：1
|
作者：
Jahagirdar, R. [1 ]
Genest, J. [2 ]
Hansen, H. C. [1 ]
Nicholls, C. D. [1 ]
Attwell, S. [1 ]
McLure, K. G. [1 ]
Wagner, G. S. [1 ]
Johansson, J. [1 ]
Wong, N. C. [1 ]
机构：
[1] Resverlogix Corp, Pharmacol, Calgary, AB, Canada
[2] McGill Univ, Montreal, PQ, Canada
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2008年 / 9卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(08)70007-2
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：2 / 2
页数：1
相关论文
共 50 条
  • [21] Compound RVX-208 Modulates HDL-C Levels and Function In Non-human Primates and in Early (phase I) Human Trials
    Krimbou, Larbl
    Jahagirdar, Ravi
    Bailey, Dana
    Haliane, Anouar
    Ruel, Isabelle
    Wong, Norman
    Wagner, Gregory S.
    Chiacchia, Fabrizio
    Gordon, Allan
    Hansen, Henrik C.
    Johansson, Jan
    Genest, Jacques
    CIRCULATION, 2008, 118 (18) : S371 - S371
  • [22] Structure dynamics of ApoA-I amyloidogenic variants in small HDL increase their ability to mediate cholesterol efflux
    Nilsson, Oktawia
    Lindvall, Mikaela
    Obici, Laura
    Ekstrom, Simon
    Lagerstedt, Jens O.
    Del Giudice, Rita
    JOURNAL OF LIPID RESEARCH, 2021, 62
  • [23] Low HDL-C is associated with a decrease of an APOA-I only HDL subpopulation.
    Roheim, PS
    Lefevre, M
    Tulley, R
    Tierney, C
    Wong, L
    Asztalos, B
    FASEB JOURNAL, 1996, 10 (03): : 3177 - 3177
  • [24] HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes
    Waldman, Boris
    Jenkins, Alicia J.
    Davis, Timothy M. E.
    Taskinen, Marja-Riitta
    Scott, Russell
    O'Connell, Rachel L.
    Gebski, Val J.
    Ng, Martin K. C.
    Keech, Anthony C.
    DIABETES CARE, 2014, 37 (08) : 2351 - 2358
  • [25] Comparison of mechanisms by which apoA-I in α- and pre-β-HDL mediates cell cholesterol efflux
    Gillotte, KL
    Lund-Katz, S
    Rothblat, GH
    Phillips, MC
    FASEB JOURNAL, 1997, 11 (09): : A1263 - A1263
  • [26] ABCA1 increases extracellular ATP to mediate cholesterol efflux to ApoA-I
    Lee, Jee Yeon
    Karwatsky, Joel
    Ma, Loretta
    Zha, Xiaohui
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2011, 301 (04): : C886 - C894
  • [27] Use of RVX-208 to increase apolipoprotein A-I and HDL in animals and phase I clinical trials
    Johansson, Jan
    Jahagirdar, Ravi
    Genest, Jacques
    Krimbou, Larbi
    Chiacchia, Fabrizio
    Wagner, Gregory
    Hansen, Henrik
    McLure, Kevin G.
    Wong, Norman C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E32 - E32
  • [28] ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression
    Burillo, Elena
    Lindholt, Jes S.
    Molina-Sanchez, Pedro
    Jorge, Inmaculada
    Martinez-Pinna, Roxana
    Blanco-Colio, Luis Miguel
    Tarin, Carlos
    Torres-Fonseca, Monica Maria
    Esteban, Margarita
    Laustsen, Jesper
    Ramos-Mozo, Priscila
    Calvo, Enrique
    Lopez, Juan Antonio
    de Ceniga, Melina Vega
    Michel, Jean-Baptiste
    Egido, Jesus
    Andres, Vicente
    Vazquez, Jesus
    Meilhac, Olivier
    Martin-Ventura, Jose Luis
    THROMBOSIS AND HAEMOSTASIS, 2015, 113 (06) : 1335 - 1346
  • [29] RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease (vol 247, pg 48, 2016)
    Gilham, Dean
    Wasiak, Sylwia
    Tsujikawa, Laura M.
    Halliday, Christopher
    Norek, Karen
    Patel, Reena G.
    Kulikowski, Ewelina
    Johansson, Jan
    Sweeney, Michael
    Wong, Norman C. W.
    ATHEROSCLEROSIS, 2016, 253 : 345 - 345
  • [30] ApoA-I oligomers generated by heparan sulphate remodeling of HDL-SAA promote cholesterol efflux
    Tam, S. P.
    Kisilevsky, R.
    Ancsin, J. B.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2010, 17 : 108 - 109
12345